Jennifer Kissner

Jennifer Kissner has a diverse and extensive work experience in the biopharmaceutical industry. Jennifer started their career at Alcon, A Novartis Division in 2007, where they held various roles including Project Head Pharmaceutical Retina, Manager of Clinical Sciences, and Senior Clinical Trial Manager. In 2012, Jennifer joined Acucela Inc. as a Director until 2014. Jennifer then moved to Clearside Biomedical, Inc. in 2014 and worked as the Senior Director of Development and later as the Vice President of Clinical Development until 2019. Currently, Jennifer is working at Outlook Therapeutics, Inc. as the Senior Vice President of Clinical Development and holds the additional role of Senior Vice President of Clinical and Regulatory Affairs since 2023.

Jennifer Kissner earned their Bachelor of Science (BS) degree in Molecular Biology from Auburn University, where they attended from 1989 to 1992. Jennifer then pursued a Doctor of Philosophy (PhD) degree in Immunology and Molecular Pathogenesis at Emory University School of Medicine, completing their studies from 1993 to 2000.